Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

K, Ikeda; S, Saitoh; Y, Arase; K, Chayama; Y, Suzuki; M, Kobayashi; A, Tsubota; I, Nakamura; N, Murashima; H, Kumada; M, Kawanishi

doi:10.1002/hep.510290439

Public

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

Published in Hepatology (Baltimore, Md.) • Apr 1, 1999

Authors:

Ikeda K

Saitoh S

Arase Y

Abstract

The activity of interferon (IFN) is not elucidated from the viewpoint of cancer prevention in chronic hepatitis C patients en masse. The hepatocellular carcinogenesis rate was analyzed statistically in 1,643 patients with chronic hepatitis C: 1,191 patients with IFN therapy and 452 without IFN thera...

View

Open Access

Generate AI Take for this paper

Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!